Trials / Terminated
TerminatedNCT03215667
Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites
Ridge Preservation With Hardening Calcium Phosphate Bone Substitutes and Resorbable Membrane for Implant Site Development on Non-containable Extraction Sites: A Clinical and Histological Prospective Case Series in Humans
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Sunstar Americas · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose of the single arm study is to clinically and histologically evaluate alloplastic in-situ hardening, moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in alveolar ridge preservation following extraction of non-molar teeth with non-containable extraction sockets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | easy-graft CLASSIC (beta-Tricalcium Phosphate) | easy-graft will be grafted to a single extraction socket and covered by polylactide membrane to facilitate regeneration of new bone in order to preserve alveolar ridge dimensions. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2019-11-03
- Completion
- 2019-11-03
- First posted
- 2017-07-12
- Last updated
- 2021-01-25
- Results posted
- 2021-01-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03215667. Inclusion in this directory is not an endorsement.